- B2B
- Scale StageRapidly increasing operations
- Top InvestorsThis company has received a significant amount of investment from top investors
- YC FundedStartup funded by Y Combinator
- Valuation $1B+This company has a valuation of $1B or more
- Recently fundedRaised funding in the past six months
- Website
- Location
- Company size
- 201-500 people
- Total raised
- $48.5M
- Company type
- Molecular DiagnosticBiotech
- Market
BillionToOne careers
We push the boundaries of molecular diagnostics through quantitative technologies.
BillionToOne is a precision diagnostics company with the mission to make molecular diagnostics more accurate, efficient, and accessible for all. Our patent-pending QCT molecular counter platform is the only technology platform that can accurately count the DNA molecules to the single-count level.
BillionToOne is a precision diagnostics company with the mission to make molecular diagnostics more accurate, efficient, and accessible for all. Our patent-pending QCT molecular counter platform is the only technology platform that can accurately count the DNA molecules to the single-count level.
BillionToOne hasn't added any jobs yet
Get notified when BillionToOne posts new jobs.
dave tsao
CTO and Co-Founder at BillionToOne. Previously engineering at Groupon.
Co-founder and CEO at BillionToOne
Total raised
$48.5M
Funded over
1 round
Latest round
Series C (Dec 2022)
Quartzy • Houston • 2 weeks ago
Penumbra • Berlin • 2 weeks ago
Vidyard • Canada • 3 weeks ago
Houzz • Nepal • 4 weeks ago
Pinterest • Toronto • 4 weeks ago